Global Lyme disease Market Outlook

The global marketplace for Lyme disease diagnostic is projected to grow due to the accelerating number of patients affected by Lyme diseases. Lyme disease is a communicable disease caused by bacterial infection namely species borrelia. The patient affected by this disease shows symptoms like fatigue, depression, fever, and skin rashes. If the patient suffering from Lyme disease is diagnosed at an early stage can be treated with the use of antibiotics. However, if the patient is not treated as early as possible the bacteria affects joints, heart, and central nervous system or in some cases, it may lead to death. The Lyme disease Diagnostic Market is predicted to register a CAGR of 6.5% during the forecast period.



Top Driver: increase the focus of the state toward the improvement of healthcare facilities
The rise in prevalence of Lyme disease increases the focus of the state toward the improvement of healthcare facilities, and the emergence of the latest Lyme disease diagnostic tests drives the market. However, lack of awareness regarding the disease and inefficiency in Lyme disease testing majorly restricts the market. In addition, growth in interests of key players toward R&D of Lyme disease diagnosis is predicted to supply lucrative growth opportunities for the market.

The diagnostic technology utilized in various laboratories also includes lymphocytic transformation tests, urine antigen tests, macromolecule tests, immunofluorescent staining, and a few others. Novel techniques are being developed to diagnoses Lyme disease that can also be used to diagnose chronic Lyme infection with the help of blood samples. The availability of those tests will reduce the matter of accuracy that came up during the serology-based tests.

Serological test -type to Make Crucial Contribution for the Growth of Lyme disease Market
The Lyme disease diagnostic market is predicated on emerging diagnostic technologies, diagnostic tests, and end-users. There are various sorts of diagnostic tests utilized in laboratories for Lyme disease testing. The most preferred mode of the test is the serological test. In the serological test, Western Blot and ELISA are the 2 most ordinarily used tests. The end-users segment includes public health labs, hospitals, physician’s offices, and commercial/private labs.

The serological test is predicted to register high revenue growth over the forecast years, thanks to the wide application of varied sorts of blood tests for diagnoses of varied disease conditions. Among the end-user segments, the hospital is expected to register the highest CAGR over the forthcoming years and is expected to dominate the market. This is primarily attributed to, the availability of economic test kits for the detection of Lyme diseases.

The Asia Pacific is expected to witness the fastest growth in Lyme disease Market
As per the geography, the worldwide marketplace for Lyme disease diagnostic is leading in North America, where it holds a maximum amount of shares. The common prevalence of tick disease within the U.S. has made the region lead the global market. The Centre for Disease Control and Prevention (CDC) states that thousands of individuals are diagnosed with Lyme disease only within the U.S. As per the analysis, the prevalence of Lyme disease is seen in the Asia Pacific and Europe which can further boost the demand for Lyme disease diagnostic market.
The market in the Asia Pacific is predicted to realize market growth during the forecast years, thanks to the rising prevalence of Lyme diseases. In addition, the increasing demand for better diagnostic tests for the disease is increasing as well as the novel development of a more accurate test of Lyme diseases for proper diagnosis and treatment.

Players to Focus on Lyme disease Market
The report also gives in-depth information about the key players within the market within the competitive landscape segment. The prominent players within the global Lyme diseases diagnostic market are
• Abbott Laboratories,
• Bio-Rad,
• Affymetrix, Inc.,
• Roche Diagnostics,
• T2 Biosystems,
• Canon Life Sciences
Scope of the Report
By Emerging Diagnostic Technology
• Serological Test
o ELISA
o Western Blot
• Urine Antigen Tests
• Lymphocytic Transformation Test
• Immunofluorescent Staining
• Nucleic acid Test
By End-User
• Hospitals
• Public/Private Laboratories
• Physicians Office
By Region
• North America
• Europe
• Asia Pacific
• Rest Of World

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.

2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.

3. It renders a definite analysis for changing competitive dynamics.

4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation

Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted

Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary

Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis

Chapter 5 Global Lyme disease Market Forces
5.1 What’s Driving the Market
5.2 Porter’s Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition

Chapter 6 Global Lyme disease Market -Industry Snapshots
6.1 Overview
6.1.1 Global Lyme disease Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis

Chapter 7 Global Lyme disease Market Analysis, by Product TypeEmerging Diagnostic Technology
7.1 Overview
7.2 Key Findings for Lyme disease Market- By Emerging Diagnostic Technology Lyme disease Market- Serological Test
7.3 Lyme disease market by Emerging Diagnostic Technology 1, 2019 - 2028 (USD Million)
7.3.1 Lyme disease Market- Urine Antigen Tests

Chapter 8 Global Lyme disease Market Analysis, by End User
8.1 Overview
8.2 Key Findings for Lyme disease Market- By Product Type
8.2.1 Lyme disease Market- Public/Private Laboratories
Lyme disease market by End user 1, 2019 - 2028 (USD Million)
8.2.2 Lyme disease Market- Hospitals Public/Private Laboratories
Lyme disease market by Commercial
8.2.3 Lyme disease Market- Physicians Office

Chapter 9 Lyme disease Market Analysis by Region
9.1 Key Findings for Lyme disease Market- By region
9.2 Overview
9.2.1 Global Lyme disease Market Analysis, By Type, 2019 - 2028
9.2.2 Global Lyme disease Market Analysis, By Product Type, 2019 - 2028
9.3 Lyme disease Market – North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Product Type
9.4 Lyme disease Market – Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Product Type
9.5 Lyme disease Market – Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Product Type
9.6 Lyme disease Market – Rest Of World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 South America
9.6.4 Rest Of World
9.6.5 South America, Middle East and Africa Market, By Type
9.6.6 South America, Middle East and Africa Market, By Product Type

Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments

Chapter 11 Company Profiles- Snapshot
11.1.1 Abbott Laboratories
11.1.2 Business Fundamentals
11.1.3 Financial Snapshots
11.1.4 Product Portfolio
11.1.5 Recent Developments
11.2 Bio-Rad,
11.3 Affymetrix, Inc.,
11.4 Roche Diagnostics,
11.5 T2 Biosystems,
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies

Chapter 12 Appendix

List Of Tables

TABLE 1 Lyme disease market by Emerging Diagnostic Technology 2, 2019 - 2028 (USD Million)
TABLE 2 2, 2019 - 2028 (USD Million)
TABLE 3 Lyme disease market by End User 3, 2019 - 2028 (USD Million)
TABLE 4 Global Lyme disease Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 5 Global Lyme disease Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 6 Lyme disease Market Analysis by North America (USD Million), 2019 - 2028
TABLE 7 U.S. Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 8 U.S. Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 9 U.S. Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 10 Canada Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 11 Canada Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 12 Canada Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 13 Mexico Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 14 Mexico Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 15 Mexico Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 16 Lyme disease Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 17 Germany Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 18 Germany Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 19 Germany Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 20 United Kingdom Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 21 United Kingdom Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 22 United Kingdom Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 23 France Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 24 France Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 25 France Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 26 Italy Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 27 Italy Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 28 Italy Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 29 Rest Of Europe Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 30 Rest Of Europe Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 31 Rest Of Europe Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 32 Lyme disease Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 33 China Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 34 China Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 35 China Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 36 Japan Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 37 Japan Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 38 Japan Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 39 India Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 40 India Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 41 India Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 42 Rest of APAC Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 43 Rest of APAC Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 44 Rest of APAC Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 45 Lyme disease Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 46 Middle East & Africa (MEA) Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 47 Middle East & Africa (MEA) Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 48 Middle East & Africa (MEA) Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 49 South America Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 50 South America Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 51 South America Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 52 Rest Of World Lyme disease Market, 2019 - 2028 (USD Million)
TABLE 53 Rest Of World Lyme disease Market, By Type, 2019 - 2028 (USD Million)
TABLE 54 Rest Of World Lyme disease Market, By Product Type, 2019 - 2028 (USD Million)

List Of Figures

FIG. 1 Global Coffee capsule: Market Segmentation
FIG. 2 Global Lyme disease Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porter’s Five Forces Analysis
FIG. 6 Global Lyme disease Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Lyme disease Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Lyme disease Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Lyme disease Market Value, 2019 - 2028, (US$ Bn)
FIG. 11 North America Lyme disease Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 Lyme disease Market Segment 1 – North America
FIG. 13 Lyme disease Market Segment 2 – North America
FIG. 14 Lyme disease U.S. outlook, 2019 & 2026
FIG. 15 Lyme disease Canada outlook, 2019 & 2026
FIG. 16 Lyme disease Mexico outlook, 2019 & 2026
FIG. 17 Europe Lyme disease Market Value, 2019 - 2028, (US$ Bn)
FIG. 18 Lyme disease Market Segment 1 – Europe
FIG. 19 Lyme disease Market Segment 2 – Europe
FIG. 20 Lyme disease Germany outlook, 2019 & 2026
FIG. 21 Lyme disease United Kingdom outlook, 2019 & 2026
FIG. 22 Lyme disease France outlook, 2019 & 2026
FIG. 23 Lyme disease Italy outlook, 2019 & 2026
FIG. 24 Lyme disease Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Lyme disease Market Value, 2019 - 2028, (US$ Bn)
FIG. 26 Lyme disease Market Segment 1 – Asia Pacific
FIG. 27 Lyme disease Market Segment 2 – Asia Pacific
FIG. 28 Lyme disease China outlook, 2019 & 2026
FIG. 29 Lyme disease Japan outlook, 2019 & 2026
FIG. 30 Lyme disease India outlook, 2019 & 2026
FIG. 31 Lyme disease Rest of APAC outlook, 2019 & 2026
FIG. 32 Rest Of World Lyme disease Market Value, 2019 - 2028, (US$ Bn)
FIG. 33 Lyme disease Market Segment 1 – Rest Of World
FIG. 34 Lyme disease Market Segment 2 – Rest Of World
FIG. 35 Lyme disease Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Lyme disease South America outlook, 2019 & 2026
FIG. 37 Lyme disease Rest Of World outlook, 2019 & 2026

Fill The Form For Sample Request

There is no Reviews available